Navigation Links
DelMar Pharmaceuticals Gives Quarterly Shareholder Update
Date:11/11/2013

83 with market exclusivity following approval for seven years in the United States and ten years in Europe.

Earlier this year, we announced that a new patent covering methods for synthesizing VAL-083 had been granted to us by the United States Patent & Trademark Office.  We continue to prosecute this as well as our other patent applications on a worldwide basis and we anticipate that additional patents will be granted in the future. 

We Are Developing a Commercial Opportunity for VAL-083 in China
In 2006, VAL-083 received national approval in China as a treatment for both chronic myelogenous leukemia (CML) and lung cancer.  However, the drug has never been actively marketed for the treatment of these diseases. In 2012, we established a collaboration and exclusive global supply agreement with Guangxi Wuzhou Pharmaceuticals, the only company licensed by the Chinese Food and Drug Administration to manufacture VAL-083 for the China market.  We are working closely with our partner to support their cGMP qualification as an exclusive supplier for our global development of VAL-083.

Our research suggests that VAL-083 may have a valuable place in the modern treatment of CML and lung cancer, both in China and worldwide.  During the past quarter, we established a clinical advisory board with leading cancer physicians in China.  Our intention is to work with these clinicians and our partner, Guangxi Wuzhou Pharmaceuticals, to develop new post-market clinical data to support the utility of VAL-083 in the context of modern care under its existing approval in China.  We believe these new clinical data, if favorable, would allow for the repositioning of VAL-083 in the China market as well as expanding its prospects for worldwide development
'/>"/>

SOURCE DelMar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Potential Treatment for Three Chemotherapy Resistant Cancers
2. DelMar Pharma reviews glioblastoma clinical trials and new therapeutic development on CEOLIVE.TV
3. DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals Establish Clinical Advisory Board in China
4. DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference
5. DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
6. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
7. DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com June 6th
8. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
9. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
10. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
11. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 30, 2014 /PRNewswire-iReach/ -- This is a professional ... Heparin sodium (CAS 9041-08-1) & calcium (CAS 37270-89-6) ... of Heparin sodium (CAS 9041-08-1) & calcium (CAS ... The report then explores global and China,s top ... (CAS 37270-89-6) listing their product specification, capacity, production ...
(Date:7/30/2014)... ANTONIO , July 30, 2014   ... company focused on innovating lifesaving devices and methods ... $4.5 million in Series A financing, which was ... Proceeds from the deal will allow Bluegrass Vascular ... Access Catheter System, enhance manufacturing capabilities, and proceed ...
(Date:7/30/2014)... California , July 30, 2014 ... technology and CUDA programming expertise to big data, ... markets  eInfochips, a leading engineering R&D ... clients to develop NVIDIA GPU-powered solutions for ... high-performance computing (HPC), industrial , ...
Breaking Medicine Technology:Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds 2eInfochips to Develop NVIDIA GPU-powered Solutions for Aerospace and Defense, Medical Imaging, HPC and Visual Computing 2
... Reportlinker.com announces that a new market research ... Pharmaceuticals: Global Industry Guide ... Pharmaceuticals: Global Industry Guide is ... analysis covering the Pharmaceuticals industry. It includes ...
... 2012 Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE ... three lead drugs (Zertane™ completed two phase ... licensing distribution of these drugs and engaged in further ... interim review of the first 50% of patients enrolled ...
Cached Medicine Technology:Pharmaceuticals: Global Industry Guide 2Pharmaceuticals: Global Industry Guide 3Pharmaceuticals: Global Industry Guide 4Pharmaceuticals: Global Industry Guide 5Pharmaceuticals: Global Industry Guide 6Pharmaceuticals: Global Industry Guide 7Pharmaceuticals: Global Industry Guide 8Pharmaceuticals: Global Industry Guide 9Pharmaceuticals: Global Industry Guide 10Pharmaceuticals: Global Industry Guide 11Pharmaceuticals: Global Industry Guide 12Pharmaceuticals: Global Industry Guide 13Pharmaceuticals: Global Industry Guide 14Pharmaceuticals: Global Industry Guide 15Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule 2Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule 3Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule 4
(Date:7/30/2014)... during deployment, returning National Guard soldiers were more ... with civilian life setbacks, including job loss, legal ... commonplace in military families. Results of the study ... Public Health are published online in the ... abuse is a major concern for reservists returning ...
(Date:7/30/2014)... “United States Orthopedic Braces and Supports Market ... States Orthopedic Braces and Supports market. The report provides value, ... average price data (in US dollars), within market categories:, ... Ankle Braces and Supports , Spinal Braces and ... , Orthotics is a specialty within the medical field ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Within weeks freshman will ... and promise. Each hopes this will be a time of growth ... for each to pause; it may not be as easy as ... of students will switch their major at least once and many ... and energy and the costs are exacerbated when switching in the ...
(Date:7/30/2014)... Falls Church, VA (PRWEB) July 30, 2014 ... Investigations , Understanding Advanced Critical Thinking Skills and ... , **Presented by Immel Resources and FDAnews**, Sept. ... , CAPA has been the #1 reason for ... plan makes it clear: Developing a successful CAPA ...
(Date:7/30/2014)... 2014 Good Neighbor Community Services ... upcoming episode of Innovations with Ed Begley Jr, ... and show times TBA. , In this segment, ... Services’ vision to redefine the traditional approach to ... services. Through passion, innovation, determination, excellence, and collaboration, ...
Breaking Medicine News(10 mins):Health News:Vets' alcohol problems linked to stress on the home front 2Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 2Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 3Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 4Health News:Advice to College Freshman from Author Garrett Miller 2Health News:Advice to College Freshman from Author Garrett Miller 3Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 2Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 3Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 4Health News:Good Neighbor Community Services to be Featured in an Upcoming Episode of Innovations With Ed Begley, Jr. 2
... Jan. 14 Optical coherence tomography,(OCT) is a ... most,successful optics technology to date in the field ... 1990s and first commercialized for medical,imaging applications by ... of fast,high-resolution diagnostic images for a variety of ...
... cue works like a Zip code helps deliver mail, researchers ... have found a way to modify the surface of stem ... that may prove useful in many areas of stem cell ... Brigham and Women,s Hospital in Boston modified the surface of ...
... have found a way to selectively block the ... the sites of injury and infection when such ... today in The Journal of Experimental Medicine. The ... diseases like rheumatoid arthritis, lupus and multiple sclerosis, ...
... oldest members of the largest,generation in U.S. history began ... 79 million baby boomers to be eligible to retire ... as 2.8 million,62-year-olds ponder retirement, in a series called ... will be reported in the newspaper and online at,USATODAY.com ...
... COVER: Hillary Clinton: ",I found my own voice.," (p. ... 2008 election by examining Hillary,Clinton,s dramatic comeback win in ... is one that will be determined by the,historically complicated ... a tough word, but ... it aptly captures how ...
... into ,skeleton, of animal organ was beating in just ... An organ-building biotechnology that could create transplantable hearts using ... laboratory tests, researchers report. , The technique, called whole ... tissue, according to a report in the Jan. 13 ...
Cached Medicine News:Health News:Optical Coherence Tomography Market to Top $800 Million by 2012 2Health News:Optical Coherence Tomography Market to Top $800 Million by 2012 3Health News:Stem Cells Modified to Home in Where They're Needed 2Health News:Researchers find new way to block destructive rush of immune cells 2Health News:Researchers find new way to block destructive rush of immune cells 3Health News:Researchers find new way to block destructive rush of immune cells 4Health News:USA TODAY to Report Special Series "Turning 62: The Retirement Boom Begins" 2Health News:NEWSWEEK: Media Lead Sheet/January 21, 2008 Issue (on newsstands Monday, January 14) 2Health News:NEWSWEEK: Media Lead Sheet/January 21, 2008 Issue (on newsstands Monday, January 14) 3Health News:NEWSWEEK: Media Lead Sheet/January 21, 2008 Issue (on newsstands Monday, January 14) 4Health News:NEWSWEEK: Media Lead Sheet/January 21, 2008 Issue (on newsstands Monday, January 14) 5Health News:Biotechnology Builds a New Heart 2Health News:Biotechnology Builds a New Heart 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: